The Bee Sting That Was Not : An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma

الملخص EN

This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody.

This case suggests a novel and unintentional effect of this therapy.

Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma.

However case reports, such as ours have illustrated omalizumab’s efficacy in the treatment of a myriad immunologic and allergic diseases.

These outcomes have broadened the understanding of omalizumab’s complex mechanism of action.